Cargando…
Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
BMJ Publishing Group
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462973/ https://www.ncbi.nlm.nih.gov/pubmed/37640481 http://dx.doi.org/10.1136/jitc-2023-007114corr1 |
| _version_ | 1785098150202048512 |
|---|---|
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10462973 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104629732023-08-30 Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 J Immunother Cancer Correction BMJ Publishing Group 2023-08-28 /pmc/articles/PMC10462973/ /pubmed/37640481 http://dx.doi.org/10.1136/jitc-2023-007114corr1 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correction Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title | Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title_full | Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title_fullStr | Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title_full_unstemmed | Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title_short | Correction: Reactivation of low avidity tumor-specific CD8+ T cells associates with immunotherapeutic efficacy of anti-PD-1 |
| title_sort | correction: reactivation of low avidity tumor-specific cd8+ t cells associates with immunotherapeutic efficacy of anti-pd-1 |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462973/ https://www.ncbi.nlm.nih.gov/pubmed/37640481 http://dx.doi.org/10.1136/jitc-2023-007114corr1 |